化学合成；用作有机、医药中间体；制备方法包括以2-(4-硝基苯基)-2-甲基丙腈为起始物料经加氢还原反应（雷尼镍为催化剂），或以2-(4-氯苯基)-2-甲基丙腈为起始物料经氨解反应。
有机合成中间体；医药中间体
合成路线1
- 步骤：将2-(4-硝基苯基)-2-甲基丙腈还原为胺（2-3）；或以2-(4-氯苯基)-2-甲基丙腈为起始物料经氨解反应制备。
- 条件：还原反应使用氯化亚锡（SnCl₂）在乙酸乙酯中回流反应2.5小时；
- 收率：95%；
- 参考文献：[1] Journal of Medicinal Chemistry, 2014, vol. 57, #11, p. 4834-4848；[2] Patent: US2009/137595, 2009, A1；[3] Patent: WO2012/116237, 2012, A2（Page/Page column 119）；[4] Patent: US2015/320727, 2015, A1（Paragraph 0555; 0556）；[5] Bioorganic and Medicinal Chemistry, 2015, vol. 23, #24, p. 7585-7596；[6] Patent: CN104411706, 2016, B（Paragraph 0201-0202）；[7] Patent: WO2006/123145, 2006, A1（Page/Page column 50）；[8] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1992, #17, p. 2203-2214；[9] Patent: WO2008/117175, 2008, A2（Page/Page column 98）；[10] Patent: WO2011/1212, 2011, A1（Page/Page column 38）；[11] Patent: US2012/108627, 2012, A1（Page/Page column 16）；[12] Acta Chemica Scandinavica (1947-1973), 1954, vol. 8, p. 1203,1207；[13] Acta Chemica Scandinavica (1947-1973), 1955, vol. 9, p. 210,214；[14] Journal of Medicinal Chemistry, 1979, vol. 22, #12, p. 1460-1464；[15] Patent: WO2006/65646, 2006, A1（Page/Page column 21-22）；[16] Bioorganic and Medicinal Chemistry Letters, 2008, vol. 18, #3, p. 1027-1030；[17] Patent: WO2005/54238, 2005, A1（Page/Page column 99）；[18] Patent: WO2008/64093, 2008, A2（Page/Page column 18）；[19] Patent: WO2013/23119, 2013, A1（Page/Page column 28）；[20] Patent: WO2014/151147, 2014, A1（Paragraph 00641）；[21] Patent: US2015/30588, 2015, A1（Page/Page column 74）；[22] Patent: EP2896622, 2015, A1（Paragraph 0135; 0136）；[23] Patent: US2015/239885, 2015, A1（Paragraph 0207; 0208）；[24] Patent: US9295673, 2016, B2（Page/Page column 359）；[25] Patent: CN103254203, 2016, B（Paragraph 0065; 0087; 0088）；[26] Patent: US9358229, 2016, B2（Page/Page column 19; 20）；[27] Patent: WO2006/122806, 2006, A2（Page/Page column 49）
